Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis

Published:2022-06 Issue:6 Volume:48 Page:1209-1216
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Wang Yizi,Song Zixuan,Zhang Shitai,Wang Xiaoying,Li Peiwen^ORCID

Funder

Shengjing Hospital

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference62 articles.

1. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;JAMA,2017

2. Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic;Jacobson,2021

3. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers;Rebbeck;J Natl Cancer Inst,1999

4. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;Domchek;JAMA,2010

5. Risk-reducing salpingo-oophorectomy and breast cancer risk reduction in the gynecologic oncology group protocol-0199 (GOG-0199);Mai;JNCI Cancer Spectr,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs?;npj Breast Cancer;2024-09-05

2. Non-genetic factors and breast cancer: an umbrella review of meta-analyses;BMC Cancer;2024-07-26

3. Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy;Obstetrics & Gynecology Science;2024-07-15

4. Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers;Obstetrics & Gynecology;2023-11-02

5. Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer;Healthcare;2023-08-21